Ligand Pharmaceuticals (LGND -2.3%) trades lower after guiding its FY13 estimates below Street...

|About: Ligand Pharmaceuticals Inco... (LGND)|By:, SA News Editor

Ligand Pharmaceuticals (LGND -2.3%) trades lower after guiding its FY13 estimates below Street consensus at its Analyst Day earlier this morning. The company now expects earn around $0.35 per share on revenue of $41M to $44M, below analysts estimates of $0.43 on $45M. (Webcast replay)